Company’s Etest® complements bioMérieux’ Vitek range of products.
bioMérieux has acquired AB BIODISK, a Swedish company whose leading product line, Etest®, is used to determine the minimum inhibitory concentration of antibiotics, antifungal agents, and antimycobacterial agents. The firm reported 2007 sales of over $20 million (13 million Euro).
According to bioMérieux, the two companies have significant commercial synergies, and the AB BIODISK product portfolio is complementary to bioMérieux’s culture media and automated VITEK® range for antibiotic susceptibility testing.
bioMérieux will commercialize AB BIODISK’s products under the bioMérieux brand.
French Biotech Hungers for Fiscal Stimuli